News
List of company announcements and press releases.
Click here for announcements regarding managers transactions.
Click here for news in Danish.
February 03, 2025 | Company Announcements
Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025January 31, 2025 | Company Announcements
Bavarian Nordic – Completion of Share Buy-Back ProgramJanuary 31, 2025 | Company Announcements
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and OlderJanuary 27, 2025 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program January 20, 2025 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program January 09, 2025 | Company Announcements
Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 MillionDecember 16, 2024 | Press Releases
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India December 13, 2024 | Company Announcements
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic December 11, 2024 | Company Announcements
Bavarian Nordic to Launch DKK 150 Million Share Buy-back ProgramNovember 29, 2024 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseNovember 15, 2024 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024October 29, 2024 | Press Releases
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine September 26, 2024 | Company Announcements
Bavarian Nordic Upgrades its Financial Guidance for 2024September 26, 2024 | Company Announcements
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines September 24, 2024 | Company Announcements
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines September 19, 2024 | Press Releases
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for AdolescentsSeptember 18, 2024 | Company Announcements
Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for AfricaSeptember 13, 2024 | Company Announcements
Bavarian Nordic Receives WHO Prequalification for Mpox VaccineSeptember 12, 2024 | Press Releases
Bavarian Nordic Provides Update on the Mpox Vaccine Supply SituationSeptember 05, 2024 | Press Releases
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of CongoSeptember 05, 2024 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseAugust 27, 2024 | Press Releases
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in SingaporeAugust 22, 2024 | Company Announcements
Bavarian Nordic Announces First Half 2024 ResultsAugust 21, 2024 | Company Announcements
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European CountryAugust 17, 2024 | Press Releases
Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders